Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
Open Access
- 7 October 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Dihydroartemisinin (DHA) has been globally recognized for its efficacy and safety in the clinical treatment of malaria for decades. Recently, it has been found that DHA inhibits malignant tumor growth and regulates immune system function in addition to anti-malaria. In parasites and tumors, DHA causes severe oxidative stress by inducing excessive reactive oxygen species production. DHA also kills tumor cells by inducing programmed cell death, blocking cell cycle and enhancing anti-tumor immunity. In addition, DHA inhibits inflammation by reducing the inflammatory cells infiltration and suppressing the production of pro-inflammatory cytokines. Further, genomics, proteomics, metabolomics and network pharmacology of DHA therapy provide the basis for elucidating the pharmacological effects of DHA. This review provides a summary of the recent research progress of DHA in anti-tumor, inhibition of inflammatory diseases and the relevant pharmacological mechanisms. With further research of DHA, it is likely that DHA will become an alternative therapy in the clinical treatment of malignant tumors and inflammatory diseases.Keywords
This publication has 137 references indexed in Scilit:
- Enhancement effect of dihydroartemisinin on human γδ T cell proliferation and killing pancreatic cancer cellsInternational Immunopharmacology, 2013
- B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cellsJournal of Allergy and Clinical Immunology, 2013
- Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma modelImmunopharmacology and Immunotoxicology, 2013
- Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin PathwayThe Journal of Immunology, 2012
- Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancerOncology Reports, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengersChemico-Biological Interactions, 2010
- T Cell Trafficking in Allergic Asthma: The Ins and OutsAnnual Review of Immunology, 2008
- Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocationInternational Immunopharmacology, 2006
- Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial actionMolecular and Biochemical Parasitology, 1991